Majzner et al (12) discovered that B7-H3 CAR T cells exhibited significant antitumor activity in vivo, leading to the regression of established solid tumors in xenograft models, including osteosarcoma, medulloblastoma, and Ewing sarcoma. Here, CD276 is linked to Ewing sarcoma.